Abstract
Let us begin by making a series of statements with which no reasonable person is likely to disagree:
-
(1)
Society derives great benefit from our existing stock of medicines, many of which have been generated by research programmes which include experiments done in healthy volunteers.
-
(2)
Present and future research programmes will yield new medicines which will be of great value to society.
-
(3)
The development of medicines would be slower, more difficult and more expensive without the participation of healthy volunteers, but it could be done nevertheless.
-
(4)
Delay in development of medicines is to the disadvantage of patients.
-
(5)
The extra costs of development of drugs are borne by patients, consumers and taxpayers, not by the manufacturer.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Association of the British Pharmaceutical Industry (1988). Guidelines for Medical Experiments in Non-patient Human Volunteers. ABPI, London
Beauchamp T. L. and Childress, J. F. (1983). Principles of Biomedical Ethics, 2nd edn. Oxford University Press, Oxford, pp. 148–58
Cardon, P. V., Dommel, F. W. Jr and Trumble, R. R. (1976). Injuries to research subjects—a survey of investigators. New Engl. J. Med., 295, 650–4
Chaput de Saintonge, D. M., Crane, G. J., Rust, N. D., Karadia, S. and Whittam, L. R. (1988). Modelling determinants of expected rewards in healthy volunteers. Pharm. Med., 3, 45–54
Darragh, A., Kenny, M., Lambe, R. and Brick, I. (1985). Sudden death of a volunteer. Lancet., 1, 93–4
Dodds-Smith, I. C. (1985). The legal implications of studies in healthy volunteers. BIRA Jl., 4, 88–91
Gillon, R. (1986). Philosophical medical ethics: Doctors and patients. Br. Med. J., 292, 466–9
Orme, M., Harry, J. Routledge, P. and Hobson, S. (1989). Healthy volunteer studies in Great Britain: the results of a survey into 12 months’ activity in this field. Br. J. Clin. Pharmacol., 27, 125–33
Reidenberg, M. M. and Lowenthal, D. T. (1968). Adverse nondrug reactions. New Engl. J. Med., 279, 678–9
Royle, J. M. and Snell, E. S. (1986). Medical research on normal volunteers. Br. J. Clin. Pharmacol., 21, 548–9
Vere, D. W. (1986). Ethics. In Glenny, H. and Nelmes, P. (Eds.), Handbook of Clinical Drug Research. Blackwell Scientific Publications, Oxford, pp. 1–32
Vere, D. W. (1988). The ethics of adverse drug reactions. Adverse Drug Reaction Bulletin No. 128, 480–3
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1990 The editors and contributors
About this chapter
Cite this chapter
Warrington, S.J. (1990). Ethical Aspects of Research in Healthy Volunteers. In: O’Grady, J., Linet, O.I. (eds) Early Phase Drug Evaluation in Man. Palgrave, London. https://doi.org/10.1007/978-1-349-10705-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-349-10705-6_12
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-10707-0
Online ISBN: 978-1-349-10705-6
eBook Packages: EngineeringEngineering (R0)